Paxlovid rebound: new study tracks how often COVID returns after treatment

NCT ID NCT05618600

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This completed study followed 917 adults with COVID-19 who were prescribed Paxlovid. Researchers wanted to see how often people test positive again after finishing the 5-day treatment. The goal is to better understand the so-called 'Paxlovid rebound' and help guide future care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Paxlovid

What this could lead to

If successful, this study could help doctors understand how often COVID-19 rebounds after Paxlovid treatment and who is most at risk.

What could go wrong

This is an observational study, not a treatment trial. It cannot prove why rebound happens or how to prevent it. Results may not apply to everyone.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COVID-19 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

COVID-19

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Scripps Research Institute

    San Diego, California, 92126, United States